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http://dx.doi.org/10.1016/j.gmbhs.2Abstract Chronic kidney disease (CKD) is a prevalent disease in the elderly population.
Oxidative stress plays an important role in the progression of adverse complications in CKD pa-
tients, and many trace elements are involved in the oxidanteantioxidant balance. We investi-
gated serum levels of copper, iron, zinc, and selenium in 145 patients at Stages 1e4 of CKD.
There were no significant differences in the copper, iron, and selenium levels between the four
stages of CKD. However, the levels of serum zinc showed a statistically decreasing trend in the
advanced stages of CKD subjects (pZ 0.005). Zinc deficiency may increase oxidative stress and
atherosclerotic complications, especially in late-stage CKD patients.
Copyright ª 2013, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
In line with the increase in life expectancy, chronic kidney
disease (CKD) has become a prevalent disease in the elderlynt of Laboratory Medicine,
Taiwan.
.net (C.-C. Lin).
an Genomic Medicine and Bioma
013.03.001population. Taiwan is an area endemic for CKD. According
to Wen et al’s study, the national prevalence of CKD is
about 11.93%, and exceeds 30% in people aged 65 years or
more.1 CKD patients have greatly increased risks for car-
diovascular events and progression to kidney failure.
Oxidative stress may play an important role leading to the
progression of complications in CKD patients. Many trace el-
ements are involved in the oxidanteantioxidant balance.rker Society. Published by Elsevier Taiwan LLC. All rights reserved.
Trace elements in chronic kidney disease 129Selenium is an essential element and a cofactor inmaintaining
the activity of glutathione peroxidase, an important antioxi-
dant enzyme in the protection of cells against destruction by
hydrogen peroxide. Copper is an integral component of many
metalloenzymes and is involved in many biological processes,
suchas ironmetabolism. Iron isoneof theelements thehuman
body is rich in. It is an important component of a number of
proteins and enzymes, such as hemoglobin, cyclooxygenase,
cytochromes, ribonucleotide reductase, hydrogenase, and
catalase. Copper and iron can catalyze the formation of
reactive oxygen species via HabereWeiss and Fenton-like re-
actions and lead to the oxidative damage of cells. Zinc is an
important and essential component of a number of proteins
and enzymes, including RNA polymerase, carbonic anhydrase,
CuZn-superoxide dismutase, and zinc finger protein. It is
recognized as a cellular antioxidant because zinc is a compo-
nent of superoxide dismutase, which can inhibit NADPH oxi-
daseanddecrease theproductionofhydroxyl radicals, andcan
thus stabilize thiols in zinc proteins.2 The aim of the present
study was to investigate the oxidation-related trace elements
copper, zinc, iron, and selenium in the serum of patients at
different stages of CKD.
Materials and methods
One hundred and forty-five subjects with a physician’s
diagnosis of CKD were recruited into this study. The pa-
tients were divided into four groups (Stages 1e4) according
to the estimated glomerular filtration rate (eGFR) values,
which were estimated by the 2009 CKD-EPI (Chronic Kidney
Disease Epidemiology Collaboration) creatinine equation3:
Stage 1, eGFR  90 mL/min/1.73 m2 with positive urinary
protein; Stage 2, eGFR 60e89 mL/min/1.73 m2 with posi-
tive urinary protein; Stage 3, eGFR 30e59 mL/min/1.73 m2;
and Stage 4, 15e29 mL/min/1.73 m2. The Ethics Review
Committee of Fooyin University Hospital approved the
study protocol (FYH-IRB-100-07-01).
Blood samples were obtained from study subjects in the
morning after an overnight fast of at least 8 hours. The
routine chemistry items were immediately checked in the
clinical laboratory. The remaining serums were stored atTable 1 Demographic and clinical characteristics of patients at
Parameter Stage 1
(n Z 16)
Stage 2
(n Z 51)
Gender, male (%) 7 (43.8) 20 (39.2)
Education, below high
school (%)
14 (87.5) 41 (80.4)
Diabetes (%) 13 (81.3) 39 (76.5)
Smoking (%) 5 (31.3) 6 (11.8)
Hypertension (%) 9 (56.3) 37 (72.5)
Age (years) 57.6  8.9 63.0  10.1
Fasting glucose (mg/dL) 140  33 160  63
Mean HbA1c (%) 7.7  1.3 7.9  1.6
Urea nitrogen (mg/dL) 13.3  2.8 17.9  4.9
Creatinine (mg/dL) 0.7  0.1 1.0  0.2
Uric acid (mg/dL) 5.2  1.1 6.2  1.5
Data are presented as mean  standard deviation (SD).
*p < 0.01.e70C until required for analysis of copper, zinc, iron, and
selenium. The serum samples for determination of the
copper, zinc, and iron levels were suitably diluted with 2%
HNO3 and measured using a flame-atomic absorption spec-
trometer (PerkinElmer, Norwalk, CT, USA) at wavelengths
of 324.8, 213.9, and 248.3 nm, respectively. The selenium
concentration was measured with a graphite furnace
atomic absorption spectrometer at wavelength 196.0 nm.
Data are expressed as mean  standard deviation (SD).
One-way analysis of variance was used for continuous var-
iables and the Chi-square test for categorical variables to
compare the differences between the four stages of CKD.
Statistical significance was implied by a value of p < 0.05.
All statistical analyses were performed using SPSS 18.0
software (SPSS Inc., Chicago, IL, USA).
Results
The patients were divided into four subgroups, Stages 1e4
(nZ 16, 51, 70, and 8 patients, respectively), according to
their eGFR values. Table 1 lists the demographic and clin-
ical characteristics and chemistry results for patients with
different stages of CKD. There were no differences in
gender, education, presence of diabetes, smoking, hyper-
tension, fasting glucose, and HbA1c level between the four
subgroups. However, there were significant differences in
age, blood urea nitrogen (BUN), creatinine, and uric acid
for the four stages of CKD (p < 0.05).
The levels of oxidation-related elements for the
different stages of CKD are shown in Table 2. There were no
significant differences in copper, iron, and selenium levels
at different stages of CKD. However, the levels of serum
zinc showed a statistically significant difference
(pZ 0.005) at different stages and a significant decreasing
trend in late-stage CKD subjects.
Discussion
The late-stage CKD patients were found to have elevated
serum levels of urea nitrogen, creatinine, and uric acid.different stages of chronic kidney disease (CKD).
Stage 3
(n Z 70)
Stage 4
(n Z 8)
Total
(n Z 145)
p
35 (50) 4 (50) 66 (45.5) 0.689
63 (90.0) 6 (75.9) 124 (85.5) 0.394
55 (78.6) 8 (100) 115 (79.3) 0.494
12 (17.1) 3 (37.5) 26 (17.9) 0.147
45 (64.3) 7 (87.5) 98 (67.6) 0.347
68.5  8.9 71.7  12.1 65.5  10.2 <0.001*
176  92 145  62 164  77 0.298
8.8  6.3 7.7  1.0 8.3  4.5 0.711
23.1  6.3 45.4  8.2 21.2  8.5 <0.001*
1.4  0.3 2.4  0.7 1.2  0.5 <0.001*
7.0  1.5 8.9  1.8 6.6  1.6 <0.001*
Table 2 Oxidation-related metals at different stages of chronic kidney disease (CKD).
Parameter Stage 1 (n Z 16) Stage 2 (n Z 51) Stage 3 (n Z 70) Stage 4 (n Z 8) Average p
Copper (ppm) 1.04  0.18 1.07  0.21 1.09  0.20 1.24  0.17 1.09  0.2 0.133
Iron (ppm) 1.26  0.45 1.27  0.38 1.16  0.44 1.36  0.59 1.22  0.43 0.347
Zinc (ppm) 0.88  0.13 0.83  0.17 0.76  0.16 0.69  0.13 0.80  0.17 0.005*
Selenium (ppb) 146.3  20.0 144.1  23.2 141.2  23.2 145.4  17.8 143.0  22.5 0.799
Data are presented as mean  standard deviation (SD).
*p < 0.01.
ppb Z parts per billion; ppm Z parts per million.
130 C.-T. Shih et al.Diabetes and hypertension are two important risk factors for
CKD. In the present study, the subjects diagnosed with dia-
betes and hypertension accounted for 79.3% and 67.6% of all
CKD patients, respectively. However, the proportion of pa-
tients with diabetes and hypertension did not vary signifi-
cantly between the different stages of CKD. On the other
hand, later stage CKD was correlated with an increased age.
This result was consistent with Wen et al’s study.1
We found no significant difference in copper, iron, and
selenium levels at different stages of CKD. However, we
found a decrease in zinc concentration in CKD patients from
Stages 1 to 4. Zinc concentrations in patients with CKD vary
depending on individual diets and medications. Batista et al
found that plasma zinc level was lower in patients on
chronic hemodialysis than the control group.4 Dashti-
Khavidaki et al reported that the mean serum zinc con-
centration in patients on maintenance hemodialysis was
significantly lower than that of the control group.5 Yilmaz
et al observed a stepwise reduction in erythrocyte zinc
concentrations with advancing stage of kidney disease.6
Zinc is a component of the important antioxidant enzyme
superoxide dismutase. A lower concentration of zinc may also
inhibit the production of metallothionein and decrease
competition with both iron and copper for binding to the cell
membrane, thereby increasing the production of hydroxyl
radicals. Zincdeficiencywill increaseoxidative stress, activate
nuclear factor kappa B, and increase the production of some
interleukins, which may contribute to atherosclerosis.7e9
Thus, lower concentrations of plasma zinc may be associated
with theprogressionofatherosclerosis inCKDpatients.Ari etal
demonstrated that the lower the zinc concentration, the
higher the intima media thickness of the carotid artery.10
In the present study, we found a significant decreasing
trend in zinc values in the late stages of kidney disease. This
may represent a sign of increased oxidative stress and
therefore an increased chance of complications of athero-
sclerosis in these patients. Future studies are needed in
order to investigate whether zinc supplements can decrease
the oxidative stress and associated atherosclerotic compli-
cations in late-stage CKD patients.Acknowledgment
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